THIS SEARCH THIS DOCUMENT GO TO Next Hit Forward New Bills Search Prev Hit Back HomePage Hit List Best Sections Help Contents Display
GPO's PDF Display | Congressional Record References | Link to House Committee Report 773 Part 1 | Bill Summary & Status | Printer Friendly Display - 15,257 bytes.[Help] |
Medical Financial Privacy Protection Act (Introduced in House)
HR 4585 IH
June 6, 2000
Mr. LEACH introduced the following bill; which was referred to the Committee on Banking and Financial Services, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
- Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
- This Act may be cited as the `Medical Financial Privacy Protection Act'.
SEC. 2. USE AND DISCLOSURE OF HEALTH INFORMATION BY FINANCIAL INSTITUTIONS.
- (a) IN GENERAL- Title V of the Gramm-Leach-Bliley Act (15
U.S.C. 6801 et seq.) is amended by inserting after section 502 the
following:
`SEC. 502A. SPECIAL RULES FOR HEALTH INFORMATION.
- `(a) RULES FOR DISCLOSURE-
- `(1) GENERAL RULE REQUIRING AFFIRMATIVE CONSENT FOR DISCLOSURE-
- `(A) IN GENERAL- A financial institution may not
disclose any individually identifiable health information pertaining to
a consumer to an affiliate or a nonaffiliated third party unless the
financial institution--
- `(i) has provided to the consumer a clear and
conspicuous notice in writing, in electronic form, or in another form
permitted by the regulations implementing this subtitle, of the
categories of such information that may be disclosed and the categories
of affiliates or nonaffiliated third parties to whom the financial
institution discloses such information;
- `(ii) has clearly and conspicuously requested
in writing, in electronic form, or in another form permitted by the
regulations implementing this subtitle, that the consumer affirmatively
consent to such disclosure; and
- `(iii) has obtained from the consumer such affirmative consent and such consent has not been withdrawn.
- `(B) WITHDRAWAL OF CONSENT- Any withdrawal of
consent is subject to the rights of any financial institution that
acted in reliance on the consent prior to its withdrawal.
- `(2) DISCLOSURE OF INFORMATION ABOUT PERSONAL SPENDING HABITS-
- `(A) IN GENERAL- If a financial institution
provides a service to a consumer through which the consumer makes or
receives payments or transfers by check, debit card, credit card, or
other similar instrument, the financial institution may not disclose
any information described in subparagraph (B) pertaining to the
consumer to an affiliate or a nonaffiliated third party unless the
financial institution has satisfied the requirements of clauses (i),
(ii), and (iii) of paragraph (1)(A) with respect to the disclosure.
- `(B) INFORMATION DESCRIBED- The information described in this paragraph is--
- `(i) an individualized list of a consumer's
transactions or an individualized description of a consumer's
interests, preferences, or other characteristics; or
- `(ii) any such list or description constructed in response to an inquiry about a specific, named individual;
- if the list or description is derived from
individually identifiable health information collected in the course of
providing a service described in subparagraph (A) to the consumer.
- `(3) DISCLOSURE OF AGGREGATE LISTS- A financial
institution may not disclose any aggregate list of consumers containing
or derived from individually identifiable health information to an
affiliate or a nonaffiliated third party unless the financial
institution has satisfied, for each consumer on the list, the
requirements of clauses (i), (ii), and (iii) of paragraph (1)(A) with
respect to the disclosure.
- `(4) EXCEPTIONS TO DISCLOSURE LIMITATIONS- This section
shall not restrict a financial institution from disclosing individually
identifiable health information--
- `(A) for a purpose described in paragraph (1), (2), (3), (5), (7), or (8) of section 502(e);
- `(B) in order to facilitate customer service, such
as maintenance and operation of consolidated customer call centers or
the use of consolidated customer account statements; or
- `(C) to the institution's attorneys, accountants, and auditors.
- `(5) LIMITS ON REDISCLOSURE AND REUSE OF INFORMATION-
- `(A) IN GENERAL- Except as provided in subparagraph
(B), an affiliate or a nonaffiliated third party that receives
individually identifiable health information from a financial
institution under this section shall not disclose such information to
any other person, unless such disclosure would be lawful if made
directly to such other person by the financial institution.
- `(B) DISCLOSURE UNDER AN EXCEPTION- Notwithstanding
subparagraph (A), any person that receives individually identifiable
health information from a financial institution in accordance with one
of the exceptions in paragraph (4) may use or disclose such information
only--
- `(i) as permitted under that exception; or
- `(ii) under another exception in such paragraph
to carry out the purpose for which the information was disclosed by the
financial institution.
- `(6) CONSTRUCTION- Except as provided in paragraph
(4)(A), this section applies in lieu of subsections (b), (c), and (e)
of section 502 to a disclosure by a financial institution of
individually identifiable health information.
- `(b) RULES FOR RECEIPT AND USE-
- `(1) IN GENERAL- In deciding whether, or on what terms,
to offer, provide, or continue to provide a loan or credit to a
consumer, a financial institution shall not request to receive
individually identifiable health information about the consumer from an
affiliate or nonaffiliated third party, or use, evaluate, or otherwise
consider any such information, unless the financial institution--
- `(A) has clearly and conspicuously requested in
writing, in electronic form, or in another form permitted by the
regulations implementing this subtitle, that the consumer affirmatively
consent to such receipt and use; and
- `(B) has obtained from the consumer such affirmative consent and such consent has not been withdrawn.
- `(2) RESTRAINT ON INFORMATION REQUESTS- In deciding
whether, or on what terms, to offer, provide, or continue to provide a
loan or credit to a consumer, a financial institution shall not request
the consent described in paragraph (1)(A) to receive individually
identifiable health information available from an affiliate, if the
financial institution would not otherwise normally receive the same or
substantially similar information from a nonaffiliated third party if
that third party were the only person able to provide the information.
- `(c) CONSUMER RIGHTS TO ACCESS AND CORRECT INFORMATION-
- `(1) ACCESS-
- `(A) IN GENERAL- Upon the request of a consumer, a
financial institution shall make available to the consumer individually
identifiable health information about the consumer that is within the
possession of the financial institution.
- `(B) EXCEPTIONS- Notwithstanding subparagraph (A), a financial institution--
- `(i) shall not be required to disclose to a
consumer any confidential commercial information, such as an algorithm
used to derive credit scores or other risk scores or predictors;
- `(ii) shall not be required to create new records in order to comply with the consumer's request;
- `(iii) shall not be required to disclose to a
consumer any information assembled by the financial institution, in a
particular matter, as part of the financial institution's efforts to
comply with laws preventing fraud, money laundering, or other unlawful
conduct; and
- `(iv) shall not disclose any information required to be kept confidential by any other Federal law.
- `(2) CORRECTION-
- `(A) OPPORTUNITY TO DISPUTE- A financial
institution shall provide a consumer the opportunity to dispute the
accuracy of any individually identifiable health information disclosed
to the consumer pursuant to paragraph (1), and to present evidence
thereon.
- `(B) AMENDMENT, CORRECTION, OR DELETION- A financial institution--
- `(i) shall amend, correct, or delete material
information identified by a consumer that is materially incomplete or
inaccurate; or
- `(ii) shall notify the consumer of--
- `(I) its refusal to make such amendment, correction, deletion;
- `(II) the reasons for the refusal; and
- `(III) the identity of the person who
created the information and shall refer the consumer to that person for
purposes of amending or correcting the information or filing with it a
concise statement of what the consumer believes to be the correct
information.
- `(3) COORDINATION AND CONSULTATION- In prescribing
regulations implementing this subsection, the Federal agencies
specified in section 504(a) shall consult with one another to ensure
that the regulations--
- `(A) impose consistent requirements on the financial institutions under their respective jurisdictions;
- `(B) take into account conditions under which
financial institutions do business both in the United States and in
other countries; and
- `(C) are consistent with the principle of technology neutrality.
- `(4) CHARGES FOR DISCLOSURES- A financial institution
may impose a reasonable charge for making a disclosure under this
subsection, which charge shall be disclosed to the consumer before
making the disclosure.
- `(d) SPECIAL REQUIREMENT TO PROTECT MENTAL HEALTH
INFORMATION- In any case in which this section requires a person to
obtain a consumer's affirmative consent to a receipt, use, or
disclosure of individually identifiable health information, the person
shall obtain a separate and specific consent with respect to any
information pertaining to the mental health or mental condition of an
individual.
- `(e) RELATIONSHIP TO OTHER LAWS- Nothing in this section shall be construed as--
- `(1) modifying, limiting, or superseding standards promulgated by the Secretary of Health and Human Services under--
- `(A) part C of title XI of the Social Security Act (42 U.S.C. 1320d et seq.); or
- `(B) section 264(c) of the Health Insurance
Portability and Accountability Act of 1996 (Public Law 104-191; 110
Stat. 2033); or
- `(2) authorizing the use or disclosure of individually
identifiable health information in a manner other than as permitted by
other applicable law.'.
- (b) DEFINITION OF INDIVIDUALLY IDENTIFIABLE HEALTH
INFORMATION- Section 509 of the Gramm-Leach-Bliley Act (15 U.S.C. 6809)
is amended by adding at the end the following:
- `(12) INDIVIDUALLY IDENTIFIABLE HEALTH INFORMATION- The
term `individually identifiable health information' means any
information, including demographic information obtained from or about
an individual, that is described in section 1171(6)(B) of the Social
Security Act (42 U.S.C. 1320d(6)(B)).'.
- (c) CLERICAL AMENDMENT- The table of contents for the
Gramm-Leach-Bliley Act is amended by inserting after the item relating
to section 502 the following:
- `Sec. 502A. Special rules for health information.'.
SEC. 3. REGULATIONS; EFFECTIVE DATE.
- (a) REGULATIONS-
- (1) REGULATORY AUTHORITY- Section 504(a) of the
Gramm-Leach-Bliley Act (15 U.S.C. 6804(a)) shall apply to the issuance
of regulations to carry out the amendments made by this Act in the same
manner as such section applies to the issuance of other regulations to
carry out subtitle A of title V of the Gramm-Leach-Bliley Act, except
as provided in paragraph (4).
- (2) AUTHORITY TO GRANT EXCEPTIONS- The regulations
issued to carry out the amendments made by this Act may include such
additional exceptions to the provisions of section 502A of the
Gramm-Leach-Bliley Act, as inserted by section 2, as are deemed
consistent with the purposes of subtitle A of title V of such Act,
except as provided in paragraph (3)(B).
- (3) SPECIAL PROTECTIONS FOR MENTAL HEALTH INFORMATION-
- (A) IN GENERAL- The regulations issued to carry out
the amendments made by this Act shall, where appropriate, include
special policies and procedures to protect the confidentiality of
individually identifiable health information relating to the mental
health or mental condition of an individual.
- (B) AUTHORITY TO GRANT EXCEPTIONS- The regulations
issued to carry out the amendments made by this Act may not include any
exception to the provisions of section 502A of the Gramm-Leach-Bliley
Act, as inserted by section 2, that diminishes the protection afforded
by such section to the confidentiality of individually identifiable
health information relating to the mental health or mental condition of
an individual.
- (4) DEADLINE- Regulations to carry out the amendments
made by this Act shall be issued in final form not later than 6 months
after the date of the enactment of this Act.
- (b) EFFECTIVE DATE- The amendments made by this Act shall
take effect 6 months after the date on which regulations are required
to be issued under subsection (a)(4), except to the extent that a later
date is specified in such regulations.
THIS SEARCH THIS DOCUMENT GO TO Next Hit Forward New Bills Search Prev Hit Back HomePage Hit List Best Sections Help Contents Display